| Primary |
| Renal Transplant |
12.2% |
| Prophylaxis |
9.2% |
| Pneumocystis Jiroveci Pneumonia |
7.1% |
| Urinary Tract Infection |
7.1% |
| Atrial Fibrillation |
6.1% |
| Hypertension |
6.1% |
| Respiratory Tract Infection |
6.1% |
| B-cell Lymphoma |
5.1% |
| Drug Use For Unknown Indication |
5.1% |
| Nocardiosis |
5.1% |
| Chronic Lymphocytic Leukaemia |
4.1% |
| Focal Segmental Glomerulosclerosis |
4.1% |
| Immunosuppression |
4.1% |
| Osteoporosis |
4.1% |
| Hiv Infection |
3.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.1% |
| Antifungal Prophylaxis |
2.0% |
| Arthritis |
2.0% |
| Candidiasis |
2.0% |
| Coronary Artery Disease |
2.0% |
|
| Vasculitis |
12.9% |
| Dyspnoea |
6.5% |
| Kidney Transplant Rejection |
6.5% |
| Leukocytoclastic Vasculitis |
6.5% |
| Leukopenia |
6.5% |
| Nausea |
6.5% |
| Overlap Syndrome |
6.5% |
| Swelling Face |
6.5% |
| Visual Acuity Reduced |
6.5% |
| Acute Hepatic Failure |
3.2% |
| Anaemia |
3.2% |
| Cleft Lip And Palate |
3.2% |
| Confusional State |
3.2% |
| Congenital Neurological Disorder |
3.2% |
| Dizziness |
3.2% |
| Erythema |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Grand Mal Convulsion |
3.2% |
| Hepatitis |
3.2% |
| Hepatitis Toxic |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
20.4% |
| Hiv Infection |
14.0% |
| Drug Use For Unknown Indication |
13.9% |
| Prophylaxis |
13.8% |
| Burkitt's Lymphoma |
5.2% |
| Hypertension |
3.9% |
| Psoriatic Arthropathy |
3.3% |
| Immunosuppression |
2.6% |
| Tuberculosis |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| B-cell Lymphoma |
2.1% |
| Multiple Myeloma |
2.1% |
| Urinary Tract Infection |
2.0% |
| Infection Prophylaxis |
1.9% |
| Antiretroviral Therapy |
1.9% |
| Pneumocystis Jiroveci Pneumonia |
1.8% |
| Pneumonia |
1.7% |
| Renal Transplant |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Respiratory Tract Infection |
1.4% |
|
| Vomiting |
10.1% |
| Pyrexia |
8.5% |
| Renal Failure Acute |
7.7% |
| Renal Impairment |
7.3% |
| Stevens-johnson Syndrome |
6.5% |
| Weight Decreased |
6.0% |
| Cardiomyopathy |
5.6% |
| Thrombocytopenia |
5.6% |
| Neutrophil Pelger-huet Anomaly Present |
5.2% |
| Rash |
4.8% |
| White Blood Cell Count Decreased |
4.4% |
| Pancytopenia |
3.6% |
| Pregnancy |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Hepatitis |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Myalgia |
3.2% |
| Drug Interaction |
2.8% |
| Histiocytosis Haematophagic |
2.4% |
| Hyperkalaemia |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.4% |
| Prophylaxis |
14.9% |
| Hiv Infection |
12.4% |
| Drug Use For Unknown Indication |
11.1% |
| Diffuse Large B-cell Lymphoma |
6.7% |
| Multiple Myeloma |
5.2% |
| Hypertension |
3.6% |
| Infection Prophylaxis |
3.3% |
| Chronic Lymphocytic Leukaemia |
3.0% |
| Antifungal Prophylaxis |
2.9% |
| Renal Transplant |
2.8% |
| Pain |
2.7% |
| Acute Lymphocytic Leukaemia |
2.7% |
| B-cell Lymphoma |
2.0% |
| Rheumatoid Arthritis |
1.7% |
| Hodgkin's Disease |
1.6% |
| Non-hodgkin's Lymphoma |
1.5% |
| Sarcoma Metastatic |
1.2% |
| Depression |
1.2% |
| Antiviral Prophylaxis |
1.2% |
|
| Vomiting |
9.3% |
| Pyrexia |
8.8% |
| Febrile Neutropenia |
6.9% |
| Sepsis |
6.8% |
| Urinary Tract Infection |
6.8% |
| White Blood Cell Count Decreased |
6.1% |
| Pneumonia |
5.5% |
| Death |
5.4% |
| Respiratory Failure |
5.1% |
| Thrombocytopenia |
5.1% |
| Renal Failure |
4.8% |
| Neutropenia |
4.5% |
| Renal Failure Acute |
3.8% |
| Infection |
3.7% |
| Pancytopenia |
3.6% |
| Weight Decreased |
3.5% |
| Immune Reconstitution Syndrome |
2.6% |
| Somnolence |
2.6% |
| Interstitial Lung Disease |
2.5% |
| Renal Impairment |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
17.3% |
| Drug Use For Unknown Indication |
10.6% |
| Prophylaxis |
9.6% |
| Hypertension |
8.7% |
| Alcoholic Liver Disease |
5.8% |
| Myocardial Ischaemia |
5.8% |
| Peritonitis Bacterial |
5.8% |
| B-cell Lymphoma |
4.8% |
| Dermatomyositis |
3.8% |
| Psoriasis |
3.8% |
| Psoriatic Arthropathy |
3.8% |
| Urinary Tract Infection |
3.8% |
| Antifungal Prophylaxis |
2.9% |
| Cytomegalovirus Infection |
1.9% |
| Depression |
1.9% |
| Fungal Infection |
1.9% |
| Lung Transplant |
1.9% |
| Pneumocystis Jiroveci Pneumonia |
1.9% |
| Respiratory Tract Infection |
1.9% |
| Stem Cell Transplant |
1.9% |
|
| Drug Interaction |
19.2% |
| Hyperkalaemia |
15.4% |
| Pregnancy |
15.4% |
| Respiratory Failure |
7.7% |
| Urinary Tract Infection |
7.7% |
| Amnesia |
3.8% |
| Hypoglycaemia |
3.8% |
| Hyponatraemia |
3.8% |
| Iiird Nerve Paralysis |
3.8% |
| Puncture Site Haemorrhage |
3.8% |
| Renal Impairment |
3.8% |
| Sudden Cardiac Death |
3.8% |
| Tenderness |
3.8% |
| Ventricular Arrhythmia |
3.8% |
|
